Albert Kheradpour
Pediatrics · Loma Linda, CANPI 1750304408
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,987 of the $3,015 with a category attached, or 65.9%. 12 manufacturers reported payments, led by Daiichi Sankyo Inc. at 54.0% of the total. Reporting peaked in 2019 at $1,849 and has fallen 90.8% since, to $171 in 2025. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $91.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$2K
- Jazz Pharmaceuticals Inc.$303
- Adaptive Biotechnologies Corporation$263
- Novartis$192
- USWM, LLC$131
- Sobi, Inc$123
- plus $374 from 6 others
Across 107 payments — averaging $11,446 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$836K
- Novartis$221K
- E.r. Squibb & Sons, L.L.C.$97K
- Eisai Inc.$29K
- Pfizer$19K
- Incyte Corporation$9K
- plus $15K from 5 others
What the payments were for
- Travel & lodging$1,02834%
- Food & beverage$1,98766%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $1,629 |
| Jazz Pharmaceuticals Inc. | 3 | $303 |
| Adaptive Biotechnologies Corporation | 3 | $263 |
| Novartis | 2 | $192 |
| USWM, LLC | 3 | $131 |
| Sobi, Inc | 1 | $123 |
| Rigel Pharmaceuticals, Inc. | 1 | $120 |
| Amgen | 1 | $100 |
| Y-mabs Therapeutics, Inc. | 2 | $70 |
| Stemline Therapeutics Inc. | 1 | $32 |
| HEMA Biologics, LLC | 1 | $30 |
| AstraZeneca | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,015 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.
Other pediatrics in Loma Linda
- Ravi MandapatiLoma Linda$23K
- Laurene MascolaLos Angeles$451K
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Lawrence SherRolling Hills Estates$297K
- Steven BlackOakland$228K
- Jonathan StroberSan Francisco$164K
- Hasmukh AminBakersfield$140K
- Colleen KraftNewport Beach$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.